KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $32.6 million.

  • Dynavax Technologies' Free Cash Flow rose 7985.76% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.5 million, marking a year-over-year increase of 25525.81%. This contributed to the annual value of $60.2 million for FY2024, which is 3763.15% down from last year.
  • Latest data reveals that Dynavax Technologies reported Free Cash Flow of $32.6 million as of Q3 2025, which was up 7985.76% from $22.0 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Free Cash Flow peaked at $117.5 million during Q4 2021, and registered a low of -$52.4 million during Q1 2022.
  • For the 5-year period, Dynavax Technologies' Free Cash Flow averaged around $30.0 million, with its median value being $27.3 million (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 81136.75% in 2021, then tumbled by 24455.01% in 2022.
  • Quarter analysis of 5 years shows Dynavax Technologies' Free Cash Flow stood at $117.5 million in 2021, then plummeted by 71.6% to $33.4 million in 2022, then plummeted by 63.9% to $12.0 million in 2023, then soared by 311.3% to $49.5 million in 2024, then plummeted by 34.2% to $32.6 million in 2025.
  • Its last three reported values are $32.6 million in Q3 2025, $22.0 million for Q2 2025, and -$23.6 million during Q1 2025.